Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

18. Novembre 2024

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2690


	Articles 1 - 20 / 53789

	The role of pyroptosis in cancer: key components and therapeutic potential. Cell Commun Signal Liu Z, Xu S, Chen L, Gong J, Wang M. PMID: 39548573 [PubMed - indexed for MEDLINE]
	New Therapeutic Targets in RAS Wild-type Pancreatic Cancer. Curr Treat Options Oncol Diab M. PMID: 39546212 [PubMed - as supplied by publisher]
	Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial). Pleura Peritoneum Di Giorgio A, Ferracci F, Bagalà C, Carbone C, Salvatore L, Strippoli A, Attalla El Halabieh M, Abatini C, Alfieri S, Pacelli F, Tortora G. PMID: 39544430 [PubMed]
	Survey of Experts' Opinions on the Diagnosis and Management of Pancreatic Cystic Neoplasms. Korean J Radiol Yoon JH, Cho IR, Chang W, Kim B, Jang S, Kim YY, Kim JW, Lee SH, Lee JM. PMID: 39543866 [PubMed - as supplied by publisher]
	Single-cell RNA sequencing reveals the landscape of the cellular ecosystem of primary hepatocellular carcinoma. Cancer Cell Int Yin Z, Song Y, Wang L. PMID: 39543644 [PubMed]
	Prediction of 12-month recurrence of pancreatic cancer using machine learning and prognostic factors. BMC Med Inform Decis Mak Nopour R. PMID: 39543603 [PubMed - indexed for MEDLINE]
	Therapeutic potential of Î²-hydroxybutyrate in the management of pancreatic neoplasms: exploring novel diagnostic and treatment strategies. Lipids Health Dis Vaezi MA, Nekoufar S, Robati AK, Salimi V, Tavakoli-Yaraki M. PMID: 39543582 [PubMed - indexed for MEDLINE]
	Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies. Biochim Biophys Acta Mol Cell Biol Lipids Daya T, Breytenbach A, Gu L, Kaur M. PMID: 39542394 [PubMed - as supplied by publisher]
	Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis. Lancet Oncol Mastrantoni L, Chiaravalli M, Spring A, Beccia V, Di Bello A, Bagalà C, Bensi M, Barone D, Trovato G, Caira G, Giordano G, Bria E, Tortora G, Salvatore L. PMID: 39542008 [PubMed - as supplied by publisher]
	A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: the AVATAR Trial. Clin Cancer Res Sarno F, Tenorio J, Perea S, Medina L, Pazo-Cid R, Juez I, Garcia-Carbonero R, Feliu J, Guillen-Ponce C, Lopez-Casas PP, Guerra C, Duran Y, López-Acosta JF, Alonso C, Esquivel E, Dopazo A, Akshinthala D, Muthuswamy SK, Lapunzina P, Bockorny B, Hidalgo M. PMID: 39540844 [PubMed - as supplied by publisher]
	Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization. United European Gastroenterol J Tacelli M, Partelli S, Falconi M, Arcidiacono PG, Capurso G. PMID: 39540703 [PubMed - as supplied by publisher]
	Organoid-based precision medicine in pancreatic cancer. United European Gastroenterol J Beutel AK, Ekizce M, Ettrich TJ, Seufferlein T, Lindenmayer J, Gout J, Kleger A. PMID: 39540683 [PubMed - as supplied by publisher]
	KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGFâ€‘Î² mediated epithelialâ€‘mesenchymal transition. Mol Med Rep Guo Y, Hu C, Cai K, Long G, Cai D, Yu Z, Huang X, Cai Z, Hu P, Chen Y, Gao F, Wu X. PMID: 39540351 [PubMed - indexed for MEDLINE]
	A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation. Front Immunol Wang R, Liu J, Jiang B, Gao B, Luo H, Yang F, Ye Y, Chen Z, Liu H, Cui C, Xu K, Li B, Yang X. PMID: 39539544 [PubMed - indexed for MEDLINE]
	Long non-coding RNAs in pancreatic cancer. Clin Chim Acta Chen Y, Ye X, Hu M, Hu Y, Ding J. PMID: 39536894 [PubMed - as supplied by publisher]
	Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer. Cureus Aydin AA, Kayikcioglu E, Unlu A, Acun M, Guzel HG, Yavuz R, Ozgul H, Onder AH, Ozturk B, Yildiz M. PMID: 39525139 [PubMed]
	The onset characteristics and prognosis of patients with radiation-associated second primary malignancy: a pancancer study in the US SEER cancer registries. Transl Cancer Res Zhang Y, Wei R, Bai L, Jiao S, Milano MT, Liu H, Wei Z. PMID: 39525022 [PubMed]
	Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023. Liver Cancer Akahoshi K, Shindoh J, Tanabe M, Ariizumi S, Eguchi S, Okamura Y, Kaibori M, Kubo S, Shimada M, Taketomi A, Takemura N, Nagano H, Nakamura M, Hasegawa K, Hatano E, Yoshizumi T, Endo I, Kokudo N. PMID: 39524972 [PubMed]
	Enhancing physician support in pancreatic cancer diagnosis: New M-F-RCNN artificial intelligence model using endoscopic ultrasound. Endosc Int Open Hu SS, Duan B, Xu L, Huang D, Liu X, Gou S, Zhao X, Hou J, Tan S, He LY, Ye Y, Xie X, Shen H, Liu WH. PMID: 39524196 [PubMed]
	Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma. Sci Rep Stormoen DR, Lehn S, Mouw KW, Szallasi Z, Melchior LC, Dohn LH, Börcsok J, Rossing M, Toft BG, Pappot H. PMID: 39523403 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 53789

Page 1 de 2690



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité